Effectiveness of High Intensity Interval Training (HIIT) on Improving Cardiometabolic Health After SCI

Sponsor
Brock University (Other)
Overall Status
Completed
CT.gov ID
NCT03808363
Collaborator
(none)
8
1
1
10.4
0.8

Study Details

Study Description

Brief Summary

Testing the efficacy of high intensity interval training (HIIT), as compared to current research supporting moderate intensity continuous training (MICT), as a means to improve cardiometabolic health after spinal cord injury.

Condition or Disease Intervention/Treatment Phase
  • Other: High Intensity Interval Training
N/A

Detailed Description

This study aims to challenge the effectiveness of the current aerobic exercise recommendations for individuals with spinal cord injuries (SCI). Currently, moderate intensity continuous training (MICT) is suggested however this study intends to explore the effectiveness of high intensity interval training (HIIT). To do so, approximately 8 individuals with SCI will be undergo a 6 week HIIT intervention consisting of 3 sessions per week. With a focus on cardiometabolic health markers (listed in outcome measure section), we aim to provide support for HIIT as a viable method of mitigating cardiovascular risk in a SCI population.

Study Design

Study Type:
Interventional
Actual Enrollment :
8 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
6 week exercise intervention testing the efficacy of high intensity interval training as compared to current research supporting moderate intensity continuous exercise as a means to mitigate cardiometabolic decline following spinal cord injury6 week exercise intervention testing the efficacy of high intensity interval training as compared to current research supporting moderate intensity continuous exercise as a means to mitigate cardiometabolic decline following spinal cord injury
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
High-intensity Interval Training Versus Moderate Intensity Continuous Training as a Means to Improve Cardiometabolic Health After Spinal Cord Injury
Actual Study Start Date :
Feb 1, 2019
Actual Primary Completion Date :
May 30, 2019
Actual Study Completion Date :
Dec 15, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: High Intensity Interval Training Group

Approximately eight individuals with spinal cord injuries will participate in high intensity interval training for 6 weeks

Other: High Intensity Interval Training
Participants assigned to this group will perform a very mild 5-minute warm-up (0 resistance, and 60 rpm), followed by 5 one-minute bouts of high intensity exercise, with 90 seconds between each bout. These bouts will be followed by a 3-minute cool down (0 resistance, and 60 rpm). The high-intensity exercise will be performed at an intensity of 17 on the Borg rating of perceived exertion (RPE) scale (very hard), and the 90 second active rest intervals will be performed at an intensity of 7-9 (very, very light - very light). The exercise will be performed on the NuStep machine 3 times a week for 6 weeks.
Other Names:
  • HIIT
  • Outcome Measures

    Primary Outcome Measures

    1. Waist circumference (inches) [6 weeks]

      Central adiposity will be measured by tape measure to monitor possible weight loss

    2. Cholesterol [6 weeks]

      Total and HDL cholesterol will be measured in serum

    3. Triglycerides [6 weeks]

      Triglycerides will be measured in serum

    4. Glycated Hemoglobin (HbA1c) [6 weeks]

      Glycated hemoglobin will be measured in whole blood as an indicator of diabetic risk

    5. Tumor necrosis factor (TNF-a) [6 weeks]

      TNF-a will be used as an inflammatory representative and will be measured in serum

    6. Interleukin - 10 (IL-10) [6 weeks]

      IL-10 will will be used as an anti-inflammatory representative and will be measured in serum

    7. Pulse Wave Velocity [6 weeks]

      Arterial stiffness, a common measure for cardiac risk will be measured

    8. Blood pressure [6 weeks]

      Measured through a digital cuff, the focus will be on both systolic and diastolic

    9. Peak Oxygen Consumption (VO2 peak) [6 weeks]

      VO2 peak will be measured by a Moxus metabolic cart to determine changes in fitness

    10. C Reactive Protein (CRP) [6 weeks]

      CRP will will be used as an inflammatory representative and will be measured in serum

    11. Leptin [6 weeks]

      Leptin will will be used as a body fat representative and will be measured in serum

    12. Adiponectin [6 weeks]

      Adiponectin will will be used as a surrogate for insulin resistance and will be measured in serum

    Secondary Outcome Measures

    1. Physical Activity Enjoyment Scale (PACES) [6 weeks]

      All participants will complete the physical activity enjoyment scale (PACES) to indicate enjoyment of HIIT. With a total of 18 questions, options 1 through 7 going from a positive to a negative overall experience with the HIIT protocol will be documented.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Individuals with a spinal cord injury (paraplegia or tetraplegia, complete or incomplete) who are at least one-year post injury.

    • Declared medically stable, and able to communicate clearly in English.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Brock University St. Catherines Ontario Canada

    Sponsors and Collaborators

    • Brock University

    Investigators

    • Principal Investigator: Mitchel Gibson, BKin, Masters Student
    • Principal Investigator: Aaron Donst, BKin, Masters Student

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    David Ditor, David Ditor, PhD - Professor, Kinesiology, Brock University
    ClinicalTrials.gov Identifier:
    NCT03808363
    Other Study ID Numbers:
    • 18-022-DITOR
    First Posted:
    Jan 17, 2019
    Last Update Posted:
    Jan 18, 2020
    Last Verified:
    Jan 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by David Ditor, David Ditor, PhD - Professor, Kinesiology, Brock University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 18, 2020